This comprehensive report analyzes the global custom DNA synthesis market, providing a detailed forecast of its trajectory through 2032. The study explores key segments including oligonucleotide and gene synthesis, driven by critical applications in commercial and academic research sectors like gene editing and synthetic biology. By examining regional dynamics across the Americas, APAC, and Europe, the report highlights growth opportunities and competitive strategies of major industry players such as Thermo Fisher Scientific and Genescript.

Market Overview

The global Custom DNA Synthesis market is projected to experience significant growth from 2025 through 2032, expanding at a steady compound annual growth rate over the forecast period.

Technology Definition and Applications

DNA Synthesis Definition: DNA Synthesis refers to the process of artificially synthesizing DNA molecules under laboratory conditions. This is typically achieved through chemical synthesis methods, which utilize known nucleotide monomers (A, T, C, G) in a specific sequence to gradually assemble the target DNA sequence within a test tube.

Applications and Utility: DNA synthesis serves a wide range of applications within the biotechnology field, including:

• Gene cloning
• Gene editing
• Synthetic biology and other related fields

Scientific researchers and biotechnology companies utilize DNA synthesis technology to design and synthesize specific DNA sequences to facilitate research in:

• Gene function
• Biomedical research and development
• Bioinformatics

The advancement of DNA synthesis technology enables scientists to quickly and accurately synthesize DNA sequences of varying lengths and complexities, providing essential tools and support for life science research and biotechnology applications.

Regional Market Analysis

The following regions are expected to see market expansion between 2025 and 2032, growing at a consistent compound annual growth rate:

• United States: Projected to increase from 2025 through 2032.
• China: Projected to increase from 2025 through 2032.
• Europe: Projected to increase from 2025 through 2032.

Market Segmentation

By Type

• Oligonucleotide Synthesis
• Gene Synthesis

By Application

• Commercial
• Academic Research

By Region

• Americas: United States, Canada, Mexico, Brazil
• APAC: China, Japan, Korea, Southeast Asia, India, Australia
• Europe: Germany, France, UK, Italy, Russia
• Middle East & Africa: Egypt, South Africa, Israel, Turkey, GCC Countries

Competitive Landscape

Key Players

The following companies have been profiled based on primary expert input and analysis of their market coverage, product portfolios, and market penetration:

• Genescript
• Thermo Fisher Scientific
• IDT
• Eurofins Genomics
• DNA 2.0 (ATUM)
• BBI
• Azenta Life Sciences
• SBS Genetech
• Bio Basic
• Twist Bioscience
• OriGene
• Bioneer
• Eton Bioscience
• Synbio Technologies
• Eurogentec

Market Concentration

In 2025, the global market is characterized by a significant concentration of power, with the two largest companies occupying a substantial portion of the total market share.

About the Report

Report Title: Custom DNA Synthesis Industry Forecast by LP Information (LPI)

Scope and Methodology: This report provides a comprehensive analysis of the global Custom DNA Synthesis landscape. It reviews total world sales from 2025 and provides a detailed analysis of projected sales for the period of 2026 through 2032, broken down by region, market sector, and sub-sector in US$ millions.

Key Analytical Features:

• Trend Analysis: Highlights key trends regarding product segmentation, company formation, revenue, market share, latest developments, and M&A activity.
• Strategic Insights: Analyzes the strategies of leading global companies, focusing on their Custom DNA Synthesis portfolios and capabilities, market entry strategies, market positions, and geographic footprints.
• Market Dynamics: Evaluates key market trends, drivers, and affecting factors shaping the global outlook.
• Opportunity Identification: Breaks down forecasts by Type, Application, Geography, and Market Size to highlight emerging pockets of opportunity.
• Methodology: Utilizes a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs to offer a nuanced view of the current state and future trajectory of the global market.

• 1 Scope of the Report

  • 1.1 Market Introduction

  • 1.2 Years Considered

  • 1.3 Research Objectives

  • 1.4 Market Research Methodology

  • 1.5 Research Process and Data Source

  • 1.6 Economic Indicators

  • 1.7 Currency Considered

  • 1.8 Market Estimation Caveats

• 2 Executive Summary

  • 2.1 World Market Overview

    • 2.1.1 Global Custom DNA Synthesis Market Size (2021-2032)

    • 2.1.2 Custom DNA Synthesis Market Size CAGR by Region (2021 VS 2025 VS 2032)

    • 2.1.3 World Current & Future Analysis for Custom DNA Synthesis by Country/Region (2021, 2025 & 2032)

  • 2.2 Custom DNA Synthesis Segment by Type

    • 2.2.1 Oligonucleotide Synthesis

    • 2.2.2 Gene Synthesis

    • 2.2.3 Custom DNA Synthesis Market Size by Type

      • 2.2.3.1 Custom DNA Synthesis Market Size CAGR by Type (2021 VS 2025 VS 2032)
      • 2.2.3.2 Global Custom DNA Synthesis Market Size Market Share by Type (2021-2026)

  • 2.3 Custom DNA Synthesis Segment by Application

    • 2.3.1 Commercial

    • 2.3.2 Academic Research

    • 2.3.3 Custom DNA Synthesis Market Size by Application

      • 2.3.3.1 Custom DNA Synthesis Market Size CAGR by Application (2021 VS 2025 VS 2032)
      • 2.3.3.2 Global Custom DNA Synthesis Market Size Market Share by Application (2021-2026)

• 3 Custom DNA Synthesis Market Size by Player

  • 3.1 Custom DNA Synthesis Market Size Market Share by Player

    • 3.1.1 Global Custom DNA Synthesis Revenue by Player (2021-2026)

    • 3.1.2 Global Custom DNA Synthesis Revenue Market Share by Player (2021-2026)

  • 3.2 Global Custom DNA Synthesis Key Players Head office and Products Offered

  • 3.3 Market Concentration Rate Analysis

    • 3.3.1 Competition Landscape Analysis

    • 3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)

  • 3.4 New Products and Potential Entrants

  • 3.5 Mergers & Acquisitions, Expansion

• 4 Custom DNA Synthesis by Region

  • 4.1 Custom DNA Synthesis Market Size by Region (2021-2026)

  • 4.2 Global Custom DNA Synthesis Annual Revenue by Country/Region (2021-2026)

  • 4.3 Americas Custom DNA Synthesis Market Size Growth (2021-2026)

  • 4.4 APAC Custom DNA Synthesis Market Size Growth (2021-2026)

  • 4.5 Europe Custom DNA Synthesis Market Size Growth (2021-2026)

  • 4.6 Middle East & Africa Custom DNA Synthesis Market Size Growth (2021-2026)

• 5 Americas

  • 5.1 Americas Custom DNA Synthesis Market Size by Country (2021-2026)

  • 5.2 Americas Custom DNA Synthesis Market Size by Type (2021-2026)

  • 5.3 Americas Custom DNA Synthesis Market Size by Application (2021-2026)

  • 5.4 United States

  • 5.5 Canada

  • 5.6 Mexico

  • 5.7 Brazil

• 6 APAC

  • 6.1 APAC Custom DNA Synthesis Market Size by Region (2021-2026)

  • 6.2 APAC Custom DNA Synthesis Market Size by Type (2021-2026)

  • 6.3 APAC Custom DNA Synthesis Market Size by Application (2021-2026)

  • 6.4 China

  • 6.5 Japan

  • 6.6 South Korea

  • 6.7 Southeast Asia

  • 6.8 India

  • 6.9 Australia

• 7 Europe

  • 7.1 Europe Custom DNA Synthesis Market Size by Country (2021-2026)

  • 7.2 Europe Custom DNA Synthesis Market Size by Type (2021-2026)

  • 7.3 Europe Custom DNA Synthesis Market Size by Application (2021-2026)

  • 7.4 Germany

  • 7.5 France

  • 7.6 UK

  • 7.7 Italy

  • 7.8 Russia

• 8 Middle East & Africa

  • 8.1 Middle East & Africa Custom DNA Synthesis by Region (2021-2026)

  • 8.2 Middle East & Africa Custom DNA Synthesis Market Size by Type (2021-2026)

  • 8.3 Middle East & Africa Custom DNA Synthesis Market Size by Application (2021-2026)

  • 8.4 Egypt

  • 8.5 South Africa

  • 8.6 Israel

  • 8.7 Turkey

  • 8.8 GCC Countries

• 9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities

  • 9.2 Market Challenges & Risks

  • 9.3 Industry Trends

• 10 Global Custom DNA Synthesis Market Forecast

  • 10.1 Global Custom DNA Synthesis Forecast by Region (2027-2032)

    • 10.1.1 Global Custom DNA Synthesis Forecast by Region (2027-2032)

    • 10.1.2 Americas Custom DNA Synthesis Forecast

    • 10.1.3 APAC Custom DNA Synthesis Forecast

    • 10.1.4 Europe Custom DNA Synthesis Forecast

    • 10.1.5 Middle East & Africa Custom DNA Synthesis Forecast

  • 10.2 Americas Custom DNA Synthesis Forecast by Country (2027-2032)

    • 10.2.1 United States Market Custom DNA Synthesis Forecast

    • 10.2.2 Canada Market Custom DNA Synthesis Forecast

    • 10.2.3 Mexico Market Custom DNA Synthesis Forecast

    • 10.2.4 Brazil Market Custom DNA Synthesis Forecast

  • 10.3 APAC Custom DNA Synthesis Forecast by Region (2027-2032)

    • 10.3.1 China Custom DNA Synthesis Market Forecast

    • 10.3.2 Japan Market Custom DNA Synthesis Forecast

    • 10.3.3 Korea Market Custom DNA Synthesis Forecast

    • 10.3.4 Southeast Asia Market Custom DNA Synthesis Forecast

    • 10.3.5 India Market Custom DNA Synthesis Forecast

    • 10.3.6 Australia Market Custom DNA Synthesis Forecast

  • 10.4 Europe Custom DNA Synthesis Forecast by Country (2027-2032)

    • 10.4.1 Germany Market Custom DNA Synthesis Forecast

    • 10.4.2 France Market Custom DNA Synthesis Forecast

    • 10.4.3 UK Market Custom DNA Synthesis Forecast

    • 10.4.4 Italy Market Custom DNA Synthesis Forecast

    • 10.4.5 Russia Market Custom DNA Synthesis Forecast

  • 10.5 Middle East & Africa Custom DNA Synthesis Forecast by Region (2027-2032)

    • 10.5.1 Egypt Market Custom DNA Synthesis Forecast

    • 10.5.2 South Africa Market Custom DNA Synthesis Forecast

    • 10.5.3 Israel Market Custom DNA Synthesis Forecast

    • 10.5.4 Turkey Market Custom DNA Synthesis Forecast

  • 10.6 Global Custom DNA Synthesis Forecast by Type (2027-2032)

  • 10.7 Global Custom DNA Synthesis Forecast by Application (2027-2032)

    • 10.7.1 GCC Countries Market Custom DNA Synthesis Forecast

• 11 Key Players Analysis

  • 11.1 Genescript

    • 11.1.1 Genescript Company Information

    • 11.1.2 Genescript Custom DNA Synthesis Product Offered

    • 11.1.3 Genescript Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.1.4 Genescript Main Business Overview

    • 11.1.5 Genescript Latest Developments

  • 11.2 Thermo Fisher Scientific

    • 11.2.1 Thermo Fisher Scientific Company Information

    • 11.2.2 Thermo Fisher Scientific Custom DNA Synthesis Product Offered

    • 11.2.3 Thermo Fisher Scientific Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.2.4 Thermo Fisher Scientific Main Business Overview

    • 11.2.5 Thermo Fisher Scientific Latest Developments

  • 11.3 IDT

    • 11.3.1 IDT Company Information

    • 11.3.2 IDT Custom DNA Synthesis Product Offered

    • 11.3.3 IDT Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.3.4 IDT Main Business Overview

    • 11.3.5 IDT Latest Developments

  • 11.4 Eurofins Genomics

    • 11.4.1 Eurofins Genomics Company Information

    • 11.4.2 Eurofins Genomics Custom DNA Synthesis Product Offered

    • 11.4.3 Eurofins Genomics Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.4.4 Eurofins Genomics Main Business Overview

    • 11.4.5 Eurofins Genomics Latest Developments

  • 11.5 DNA 2.0 (ATUM)

    • 11.5.1 DNA 2.0 (ATUM) Company Information

    • 11.5.2 DNA 2.0 (ATUM) Custom DNA Synthesis Product Offered

    • 11.5.3 DNA 2.0 (ATUM) Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.5.4 DNA 2.0 (ATUM) Main Business Overview

    • 11.5.5 DNA 2.0 (ATUM) Latest Developments

  • 11.6 BBI

    • 11.6.1 BBI Company Information

    • 11.6.2 BBI Custom DNA Synthesis Product Offered

    • 11.6.3 BBI Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.6.4 BBI Main Business Overview

    • 11.6.5 BBI Latest Developments

  • 11.7 Azenta Life Sciences

    • 11.7.1 Azenta Life Sciences Company Information

    • 11.7.2 Azenta Life Sciences Custom DNA Synthesis Product Offered

    • 11.7.3 Azenta Life Sciences Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.7.4 Azenta Life Sciences Main Business Overview

    • 11.7.5 Azenta Life Sciences Latest Developments

  • 11.8 SBS Genetech

    • 11.8.1 SBS Genetech Company Information

    • 11.8.2 SBS Genetech Custom DNA Synthesis Product Offered

    • 11.8.3 SBS Genetech Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.8.4 SBS Genetech Main Business Overview

    • 11.8.5 SBS Genetech Latest Developments

  • 11.9 Bio Basic

    • 11.9.1 Bio Basic Company Information

    • 11.9.2 Bio Basic Custom DNA Synthesis Product Offered

    • 11.9.3 Bio Basic Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.9.4 Bio Basic Main Business Overview

    • 11.9.5 Bio Basic Latest Developments

  • 11.10 Twist Bioscience

    • 11.10.1 Twist Bioscience Company Information

    • 11.10.2 Twist Bioscience Custom DNA Synthesis Product Offered

    • 11.10.3 Twist Bioscience Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.10.4 Twist Bioscience Main Business Overview

    • 11.10.5 Twist Bioscience Latest Developments

  • 11.11 OriGene

    • 11.11.1 OriGene Company Information

    • 11.11.2 OriGene Custom DNA Synthesis Product Offered

    • 11.11.3 OriGene Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.11.4 OriGene Main Business Overview

    • 11.11.5 OriGene Latest Developments

  • 11.12 Bioneer

    • 11.12.1 Bioneer Company Information

    • 11.12.2 Bioneer Custom DNA Synthesis Product Offered

    • 11.12.3 Bioneer Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.12.4 Bioneer Main Business Overview

    • 11.12.5 Bioneer Latest Developments

  • 11.13 Eton Bioscience

    • 11.13.1 Eton Bioscience Company Information

    • 11.13.2 Eton Bioscience Custom DNA Synthesis Product Offered

    • 11.13.3 Eton Bioscience Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.13.4 Eton Bioscience Main Business Overview

    • 11.13.5 Eton Bioscience Latest Developments

  • 11.14 Synbio Technologies

    • 11.14.1 Synbio Technologies Company Information

    • 11.14.2 Synbio Technologies Custom DNA Synthesis Product Offered

    • 11.14.3 Synbio Technologies Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.14.4 Synbio Technologies Main Business Overview

    • 11.14.5 Synbio Technologies Latest Developments

  • 11.15 Eurogentec

    • 11.15.1 Eurogentec Company Information

    • 11.15.2 Eurogentec Custom DNA Synthesis Product Offered

    • 11.15.3 Eurogentec Custom DNA Synthesis Revenue, Gross Margin and Market Share (2021-2026)

    • 11.15.4 Eurogentec Main Business Overview

    • 11.15.5 Eurogentec Latest Developments

• 12 Research Findings and Conclusion